AntiCancer Takes New Shot At Rival Over Patents
AntiCancer Inc. has launched its second effort to convince a federal court that rival Cambridge Research & Instrumentation Inc. infringed three of its patents covering technology that uses fluorescent proteins to...To view the full article, register now.
Already a subscriber? Click here to view full article